GENECENTRIC THERAPEUTICS INC has a total of 24 patent applications. It increased the IP activity by 16.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, computer technology and pharmaceuticals are PROGENIKA BIOPHARMA SA, GENCURIX INC and GENESIS GENOMICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Canada | 4 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Computer technology | |
#3 | Pharmaceuticals | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Bioinformatics | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Healthcare informatics | |
#7 | Peptides | |
#8 | Electric digital data processing | |
#9 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Perou Charles | 24 |
#2 | Lai-Goldman Myla | 24 |
#3 | Faruki Hawazin | 23 |
#4 | Mayhew Greg | 23 |
#5 | Hayes David Neil | 18 |
#6 | Serody Jonathan | 6 |
#7 | Fan Cheng | 2 |
#8 | Parker Joel | 2 |
#9 | Zevallos Jose | 2 |
#10 | Shibata Yoichiro | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020076897A1 | Detecting cancer cell of origin | |
WO2020076900A1 | Detecting tumor mutation burden with rna substrate | |
WO2019160914A1 | Methods for subtyping of bladder cancer | |
WO2019046585A1 | Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment management | |
EP3665199A1 | Methods for subtyping of head and neck squamous cell carcinoma | |
US2020232042A1 | Methods for determining response to parp inhibitors | |
CA3024744A1 | Methods for subtyping of lung squamous cell carcinoma | |
US2019338365A1 | Methods for subtyping of lung adenocarcinoma | |
CA2982775A1 | Methods for typing of lung cancer | |
US2017114416A1 | Methods for typing of lung cancer |